ストックスクリーナーアプリを入手
559.65
0.37%
-2.06
前日終値:
$561.71
開ける：
$562.46
24時間の取引高:
2.06M
Relative Volume:
1.18
時価総額：
$214.07B
収益：
$42.37B
当期純損益:
$6.14B
株価収益率:
35.09
EPS:
15.95
ネットキャッシュフロー:
$7.78B
1週間 パフォーマンス:
+3.20%
1か月 パフォーマンス:
+5.83%
6か月 パフォーマンス:
+0.83%
1年 パフォーマンス:
+3.78%
1日の値動き範囲:
$559.11
$565.00
1週間の範囲:
$541.67
$565.00
52週間の値動き範囲:
$493.30
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
名前
Thermo Fisher Scientific Inc
セクター
電話
(781) 622-1000
住所
168 THIRD AVENUE, WALTHAM, MA
TMO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
559.65 | 214.07B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.36 | 172.16B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
147.36 | 42.09B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.36 | 35.82B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
419.26 | 34.33B | 3.84B | 866.24M | 792.60M | 10.37 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-03-18 | 再開されました | Citigroup | Neutral |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-10-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-06 | 再開されました | Citigroup | Buy |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-07-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-07-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 繰り返されました | Barclays | Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 再開されました | Barclays | Overweight |
| 2021-10-20 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-07-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 繰り返されました | Needham | Buy |
| 2020-04-23 | 繰り返されました | Needham | Buy |
| 2020-01-31 | 繰り返されました | Needham | Buy |
| 2020-01-22 | 開始されました | Credit Suisse | Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-25 | 繰り返されました | Needham | Buy |
| 2019-07-16 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-05-23 | 繰り返されました | Needham | Strong Buy |
| 2019-04-22 | 繰り返されました | Needham | Strong Buy |
| 2019-04-16 | 繰り返されました | BofA/Merrill | Buy |
すべてを表示
Thermo Fisher Scientific Inc (TMO) 最新ニュース
Cancer Biopsy Market Size is Expected to Reach USD 60.92 Billion by 2033, Growing at a CAGR of 7.81%: Straits Research - GlobeNewswire Inc.
LaFleur & Godfrey LLC Buys 2,488 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
UMB Bank n.a. Has $20.91 Million Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Annex Advisory Services LLC Increases Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Key Trends in the Bioinformatics Market with Insights from - openPR
Cohen Klingenstein LLC Lowers Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Lummis Asset Management LP Trims Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Jackson Square Capital LLC Has $3.09 Million Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Smith Salley Wealth Management Grows Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Merit Financial Group LLC Raises Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Householder Group Estate & Retirement Specialist LLC Decreases Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Arthur M. Cohen & Associates LLC Reduces Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Trust Co. of Vermont Grows Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific (BUE:TMO) EV-to-EBIT : 40.10 (As of Jan. 18, 2025) - GuruFocus.com
An Intrinsic Calculation For Thermo Fisher Scientific Inc. (NYSE:TMO) Suggests It's 31% Undervalued - Simply Wall St
29,914 Shares in Thermo Fisher Scientific Inc. (NYSE:TMO) Purchased by Avanza Fonder AB - MarketBeat
Border to Coast Pensions Partnership Ltd Acquires 10,305 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Bought by Foresight Group Ltd Liability Partnership - MarketBeat
Professional Advisory Services Inc. Has $29.12 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace
Hennion & Walsh Asset Management Inc. Acquires 2,094 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
$100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today - Benzinga
KMG Fiduciary Partners LLC Boosts Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Empirical Asset Management LLC Makes New $34.78 Million Investment in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Carnegie Investment Counsel Acquires 726 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
AI in Nanotechnology Market Top Companies StudyThermo Fisher - openPR
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Argent Capital Management LLC - MarketBeat
Lyndra Therapeutics inks manufacturing services collaboration with Thermo Fisher for long-acting oral therapies - BSA bureau
Lyndra and Thermo Fisher partner for oral therapies - Yahoo Finance
Dixon Mitchell Investment Counsel Inc. Increases Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Gateway Investment Advisers LLC Grows Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Lyndra Therapeutics partners with Thermo Fisher for long-acting therapies - World Pharmaceutical Frontiers
Park Avenue Securities LLC Reduces Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
MicroRNA Market Next Big Thing | Major Giants- Qiagen, Thermo Fisher Scientific, Merck - openPR
Fifth Third Wealth Advisors LLC Grows Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Rockland Trust Co. Purchases 1,721 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
JPM 2025: Thermo Fisher ‘very positive’ on sterile demand as Catalent takes capacity out of market - Pharmaceutical Technology
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies - BioSpace
Lyndra, Thermo Fisher Partner to Bring Long-Acting Oral Therapies to Market - Contract Pharma
Freezing Media Market Is Booming So Rapidly | Thermo Fisher, Merck, Zenoaq, Lonza - openPR
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by S.E.E.D. Planning Group LLC - MarketBeat
Covea Finance Sells 5,410 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Avity Investment Management Inc. - MarketBeat
2,413 Shares in Thermo Fisher Scientific Inc. (NYSE:TMO) Bought by Pines Wealth Management LLC - MarketBeat
R.H. Investment Group LLC Acquires Shares of 8,904 Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
CCLA Investment Management Has $134.50 Million Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Pneumonia Testing Market Is Booming Worldwide 2024-2031 | Thermo Fisher Scientific Inc., Abbott Laboratories - EIN News
Pathogen Reduction System Market Size, Trends Analysis 2031 - openPR
JP Morgan 2025: Thermo Fisher Scientific rides momentum to project strong growth in 2025 - Yahoo Finance
Genome Engineering Market Is Booming Worldwide 2024-2031 | Thermo Fisher Scientific Inc., CRISPR Therapeutics - EIN News
Thermo Fisher Scientific Inc (TMO) 財務データ
収益
当期純利益
現金流量
EPS
1.46%
1.82%
大文字化:
|
ボリューム (24 時間):